InventisBio Revenue

In the year 2025, InventisBio had annual revenue of 37.29M CNY, down -77.91%. InventisBio had revenue of 6.40M in the quarter ending December 31, 2025, a decrease of -95.73%.

Revenue

37.29M

Revenue Growth

-77.91%

P/S Ratio

344.16

Revenue / Employee

201.57K

Employees

168

Market Cap

12.83B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	37.29M	-131.50M	-77.91%
Dec 31, 2024	168.79M	-16.74M	-9.02%
Dec 31, 2023	185.53M	-	-
Dec 31, 2022	-	-	-
Dec 31, 2021	-	-	-
Dec 31, 2020	Pro	Pro	Pro
Dec 31, 2019	Pro	Pro	Pro
Dec 31, 2018	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Tibet Cheezheng Tibetan Medicine	2.42B
Staidson (Beijing) BioPharmaceuticals	203.92M
Inner Mongolia Furui Medical Science	1.60B
Vcanbio Cell & Gene Engineering Corp.,	1.42B
Pacific Shuanglin Bio-pharmacy	2.38B
Hualan Biological Vaccine	1.20B
Chengdu Olymvax Biopharmaceuticals	704.16M
Chongqing Genrix Biopharmaceutical	230.72M

Revenue Rankings